Skip to main content
. 2020 Dec 10;124(5):963–974. doi: 10.1038/s41416-020-01198-5

Fig. 1. F. nucleatum and chemotherapy response in clinical samples.

Fig. 1

Representative findings (a CT, PET, b pathology) in ESCC patients with favourable therapeutic effect. c, d Chemotherapeutic response rate according to F. nucleatum status using c SUV max response and d tumour regression grade. e The relationship between F. nucleatum DNA amount in pre-treatment biopsy specimens and RECIST.